etoposide has been researched along with Beuren Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, M; Ito, M; Kaneda, H; Morioka, I; Oba, D; Yagasaki, H | 1 |
| Borg, C; Deconinck, E; Guenat, D; Merla, G; Rohrlich, PS | 1 |
2 other study(ies) available for etoposide and Beuren Syndrome
| Article | Year |
|---|---|
Successful treatment of stage 4 rhabdomyosarcoma in a female with Williams-Beuren syndrome.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Irinotecan; Neoplasm Staging; Proton Therapy; Rhabdomyosarcoma; Vincristine; Williams Syndrome | 2020 |
DNA damage response defect in Williams-Beuren syndrome.
Topics: Case-Control Studies; Cell Cycle; Cell Line; Cell Proliferation; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Etoposide; Fibroblasts; Gene Knockdown Techniques; Gene Silencing; Genetic Predisposition to Disease; Histones; Humans; Hydroxyurea; RNA, Small Interfering; Williams Syndrome | 2017 |